Literature DB >> 21320476

Insulin resistance is associated with the metabolic syndrome and is not directly linked to coronary artery disease.

Alexander Vonbank1, Christoph H Saely, Philipp Rein, Stefan Beer, Johannes Breuss, Christian Boehnel, Heinz Drexel.   

Abstract

BACKGROUND: Insulin resistance (IR) is the key feature of the metabolic syndrome (MetS). Its association with directly visualized coronary atherosclerosis is unclear. We hypothesised that insulin resistance is associated with both angiographically determined coronary artery disease (CAD) and with the MetS.
METHODS: In 986 consecutive patients undergoing coronary angiography for the evaluation CAD, IR was determined by the HOMA index; the MetS was defined according to NCEP-ATPIII criteria; and significant CAD was diagnosed when coronary stenoses ≥50% were present.
RESULTS: HOMA IR scores were higher in MetS patients than in subjects without the MetS (4.9±6.4 vs. 2.2±2.0; p<0.001). HOMA IR did not differ significantly between patients with significant CAD and those who did not have significant CAD. When both, the presence of MetS and of significant CAD were considered, HOMA IR was significantly higher in patients with the MetS both among those who had significant CAD (4.9±6.8 vs. 2.2±1.8; p<0.001) and among those who did not have significant CAD (5.0±5.8 vs. 2.1±2.3; p<0.001), it did not differ significantly between patients with significant CAD and subjects without significant CAD among patients with the MetS nor among those without MetS. Similar results were obtained with the IDF definition of the MetS.
CONCLUSION: IR is significantly associated with the MetS but not with angiographically determined CAD. IR may play a greater role in the eventual precipitation of thrombosis than in the gradual progression of atherosclerosis.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21320476     DOI: 10.1016/j.cca.2011.02.008

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Comparison of Insulin Resistance to Coronary Atherosclerosis in Human Immunodeficiency Virus Infected and Uninfected Men (from the Multicenter AIDS Cohort Study).

Authors:  Michael I Brener; Wendy S Post; Sabina A Haberlen; Long Zhang; Frank J Palella; Lisa P Jacobson; Adrian S Dobs; Richard T George; Mallory D Witt; Matthew Budoff; Lawrence A Kingsley; Todd T Brown
Journal:  Am J Cardiol       Date:  2015-12-31       Impact factor: 2.778

2.  Serum calcium levels are associated with novel cardiometabolic risk factors in the population-based CoLaus study.

Authors:  Idris Guessous; Olivier Bonny; Fred Paccaud; Vincent Mooser; Gérard Waeber; Peter Vollenweider; Murielle Bochud
Journal:  PLoS One       Date:  2011-04-21       Impact factor: 3.240

3.  Central versus peripheral cardiovascular risk in metabolic syndrome.

Authors:  H Edgell; R J Petrella; G J Hodges; J K Shoemaker
Journal:  Front Physiol       Date:  2012-02-27       Impact factor: 4.566

4.  The effects of the metabolic syndrome on coronary artery bypass grafting surgery.

Authors:  Sevil Özkan; Fatih Özdemir; Oğuz Uğur; Refik Demirtunç; Ahmet Yavuz Balci; Mehmet Kizilay; Ünsal Vural; Mehmet Kaplan; Ibrahim Yekeler
Journal:  Cardiovasc J Afr       Date:  2016-07-13       Impact factor: 1.167

5.  Insulin resistance and coronary artery disease in non-diabetic patients: Is there any correlation?

Authors:  Jamshid Vafaeimanesh; Mahmoud Parham; Samieh Norouzi; Parinaz Hamednasimi; Mohammad Bagherzadeh
Journal:  Caspian J Intern Med       Date:  2018

6.  Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease.

Authors:  Alexander Vonbank; Christoph H Saely; Philipp Rein; Heinz Drexel
Journal:  Cardiovasc Diabetol       Date:  2013-07-17       Impact factor: 9.951

7.  Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina: a cross-sectional study.

Authors:  Olga Kruszelnicka; Andrzej Surdacki; Alain Golay
Journal:  Cardiovasc Diabetol       Date:  2013-10-09       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.